| Dr Jafet A Ojeda Rodriguez, MD | |
|
301 Fisher St, Biloxi, MS 39534-2508 | |
| (228) 376-2273 | |
| Not Available |
| Full Name | Dr Jafet A Ojeda Rodriguez |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 301 Fisher St, Biloxi, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174928865 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083A0100X | Preventive Medicine - Aerospace Medicine | 01079262A (Indiana) | Secondary |
| 207R00000X | Internal Medicine | 01079262A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jafet A Ojeda Rodriguez, MD 301 Fisher St, Biloxi, MS 39534-2508 Ph: () - | Dr Jafet A Ojeda Rodriguez, MD 301 Fisher St, Biloxi, MS 39534-2508 Ph: (228) 376-2273 |
News Archive
Solvay Pharmaceuticals has decided to undertake full Phase III development with cetrorelix for the treatment of endometriosis in women.
Wake Forest Baptist Medical Center has been awarded $4.4 million to conduct a multiple-site clinical trial testing the effectiveness of a statin drug in preventing cardiovascular events in women treated for breast cancer.
According to preliminary research presented at the American Heart Association's Scientific Sessions 2017, sexual activity is rarely associated with sudden cardiac arrest unlike suggested in popular fiction.
More than half of the states that applied to participate in a controversial CMS pilot for dual-eligible beneficiaries have either dropped out or delayed implementation of their programs, according to health policy experts. Among the 26 states that applied to participate in the CMS Financial Alignment Initiative, which stems from the Patient Protection and Affordable Care Act, six have dropped out or opted for different "customized" plans and nine have delayed their start dates (Daly, 5/23).
Lazarus Effect, a medical device company focused on the development of novel interventional devices to facilitate removal of blood clots, announced the closing of a $5 million financing. Proceeds from the financing will support EU commercialization of several approved Lazarus Effect devices, as well as regulatory filings for the Lazarus ReCover and Lazarus Cover in the United States.
› Verified 3 days ago
Danielle Kusserow Bersabe, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 920 Cedar Lake Rd Ste R, Biloxi, MS 39532 Phone: 228-207-0260 | |
Eva Magiros, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1720a Medical Park Dr, Suite 340, Biloxi, MS 39532 Phone: 228-392-7429 Fax: 228-396-3830 | |
Dr. Michael Heath Haggard, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 301 Fisher St, Biloxi, MS 39534 Phone: 228-376-0576 Fax: 228-376-0103 | |
Robert J Bonhomme, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 400 Veterans Ave, Biloxi, MS 39531 Phone: 228-523-5000 Fax: 228-523-4322 | |
Dr. Belinda Alexander, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2771 Pass Rd, Suite A, Biloxi, MS 39531 Phone: 228-385-4645 Fax: 228-385-4695 | |
Bennett W Cheney, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 147 Reynoir Street, Suite 204, Biloxi, MS 39530 Phone: 228-374-2051 Fax: 228-374-2051 | |
Dr. Rita Duboyce, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 301 Fisher St, Biloxi, MS 39534 Phone: 228-376-3084 |